UFP Technologies, Inc.

UFPT ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $68.3M $59.0M $44.9M $41.8M $15.9M $13.4M $19.8M $14.3M
Depreciation & Amortization $19.2M $14.7M $11.4M $11.9M $8.4M $8.3M $8.2M $7.8M
Depreciation — — — — — — — —
Amortization $9.8M $6.7M $4.4M $4.4M $1.3M $1.3M $1.3M $1.2M
Stock-Based Compensation $8.9M $6.8M $4.6M $3.2M $2.4M $1.8M $1.6M $1.2M
Net Cash from Operating Activities $91.9M $66.6M $41.3M $17.7M $14.3M $25.0M $31.2M $21.3M
Investing Activities
Capital Expenditures — $9.7M $10.5M $13.8M $5.4M $4.4M $5.8M $5.4M
Business Acquisitions $14.7M $197.5M $0 $20.7M $96.2M $0 $0 $77.0M
Net Cash from Investing Activities $-27.6M $-210.2M $-10.5M $1.3M $-101.5M $-4.3M $-5.8M $-82.3M
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $-58.2M $152.4M $-30.0M $-25.9M $74.0M $-285.0K $-25.0M $26.3M
Net Change in Cash $6.9M $8.2M $812.0K $-6.7M $-13.1M $20.5M $505.0K $-34.7M
Free Cash Flow — $56.9M $30.8M $4.0M $8.9M $20.7M $25.5M $15.9M
← Newer Page 1 of 3 Older →